Table of Contents
Introduction
Fluoroquinolones are a powerful class of bactericidal antibiotics that inhibit bacterial DNA replication. They are widely used to treat urinary tract infections (UTIs), respiratory infections, gastrointestinal infections, and sexually transmitted diseases. Common agents include ciprofloxacin, levofloxacin, and moxifloxacin. They exhibit broad-spectrum activity against Gram-positive, Gram-negative, and atypical organisms.
Because of their unique mechanism of action and clinical importance, fluoroquinolones are frequently tested in USMLE, NCLEX, GPAT, and NEET-PG.
Stepwise Mechanism of Action of Fluoroquinolones
- Inhibition of DNA gyrase (Topoisomerase II) in Gram-negative bacteria
Fluoroquinolones bind to and inhibit DNA gyrase, which is essential for introducing negative supercoils into bacterial DNA during replication and transcription. - Inhibition of Topoisomerase IV in Gram-positive bacteria
In Gram-positive organisms, they inhibit topoisomerase IV, which is crucial for decatenation (separation) of daughter DNA strands during cell division. - Stabilization of DNA-enzyme complex
They stabilize the complex between DNA and these enzymes, preventing re-ligation of DNA strands, leading to DNA fragmentation. - Bacterial cell death
Disruption of replication and transcription leads to irreversible DNA damage and bactericidal activity.
Pharmacokinetic Parameters of Fluoroquinolones (e.g., Ciprofloxacin)
Parameter | Value |
---|---|
Bioavailability | ~70% (oral) |
Half-life | 3–7 hours (varies by drug) |
Protein binding | 20–40% |
Metabolism | Hepatic (partial) |
Excretion | Renal (major), biliary (minor) |
CNS penetration | Moderate |
Clinical Uses of Fluoroquinolones
- Urinary tract infections (UTIs)
- Prostatitis
- Gastroenteritis (Shigella, Salmonella, Campylobacter)
- Typhoid fever
- Respiratory tract infections (levofloxacin, moxifloxacin)
- Anthrax prophylaxis (ciprofloxacin)
- STIs (e.g., Chlamydia)
- Bone and joint infections
- Tuberculosis (second-line)
Adverse Effects of Fluoroquinolones
- Tendinitis and tendon rupture
- QT interval prolongation
- CNS toxicity (seizures, dizziness, insomnia)
- GI upset – nausea, diarrhea
- Photosensitivity
- Dysglycemia (hypo/hyperglycemia)
- Arthropathy in children (contraindicated in growing age)
- C. difficile superinfection
Comparative Analysis: Ciprofloxacin vs Levofloxacin
Feature | Ciprofloxacin | Levofloxacin |
---|---|---|
Spectrum | Gram– > Gram+ | Broad (better Gram+ & atypicals) |
Respiratory coverage | Poor | Excellent |
Half-life | Short (~4 h) | Longer (~7 h) |
Dosing frequency | Twice daily | Once daily |
Practice MCQs
Q1. Fluoroquinolones inhibit which bacterial enzyme in Gram-negative organisms?
a. Topoisomerase IV
b. DNA polymerase
c. DNA gyrase ✅
d. RNA polymerase
Q2. What is the primary mechanism of fluoroquinolones?
a. Ribosomal inhibition
b. DNA replication inhibition ✅
c. Cell wall synthesis inhibition
d. Folic acid inhibition
Q3. Which of the following is a major adverse effect?
a. Hepatic failure
b. Tendon rupture ✅
c. Stevens-Johnson Syndrome
d. Pancytopenia
Q4. Fluoroquinolones are contraindicated in:
a. Elderly
b. Pregnant women
c. Children with open growth plates ✅
d. All of the above
Q5. Which fluoroquinolone is best for pneumonia?
a. Ciprofloxacin
b. Norfloxacin
c. Levofloxacin ✅
d. Ofloxacin
Q6. Fluoroquinolones cause QT prolongation by blocking:
a. Na⁺ channels
b. K⁺ channels ✅
c. Ca²⁺ channels
d. HCN channels
Q7. Which fluoroquinolone is preferred for anthrax?
a. Moxifloxacin
b. Ciprofloxacin ✅
c. Levofloxacin
d. Gatifloxacin
Q8. Which adverse effect is seen with fluoroquinolones in diabetics?
a. Dysglycemia ✅
b. Ketoacidosis
c. Hypokalemia
d. Hypocalcemia
Q9. Fluoroquinolones are time- or concentration-dependent killers?
a. Time-dependent
b. Concentration-dependent ✅
c. Both
d. Neither
Q10. Which is a second-line use of fluoroquinolones?
a. Tuberculosis ✅
b. Malaria
c. Gonorrhea
d. MRSA
FAQs
Q1: Are fluoroquinolones safe in pregnancy?
No, they are contraindicated due to risk of cartilage damage in the fetus.
Q2: Why avoid fluoroquinolones in athletes?
Because of the risk of tendinitis and tendon rupture.
Q3: Can fluoroquinolones cause QT prolongation?
Yes, especially levofloxacin and moxifloxacin.
Q4: What’s the difference between generations of fluoroquinolones?
Later generations have improved Gram+ and atypical coverage.
Q5: Do they work on anaerobes?
Minimal to no activity against strict anaerobes like Bacteroides.
References
- KD Tripathi – Essentials of Medical Pharmacology
- Goodman & Gilman – The Pharmacological Basis of Therapeutics
- Sparsh Gupta – Review of Pharmacology
- NCBI: https://www.ncbi.nlm.nih.gov/books/NBK537038/

I am pursuing MBA in pharmaceutical management from NIPER Hyderabad with a strong academic record and proven success in national-level pharmacy entrance exams. I secured AIR 61 in NIPER 2024 (MS/M.Pharm) and AIR 27 in NIPER MBA, along with AIR 147 in GPAT 2024 and AIR 907 in GPAT 2023. I also achieved AIR 6 in AIIMS CRE-2025 for Drug Store Keeper and was selected as a Pharmacist (AIR 61) for ESIC. Additionally, I was the Runner-Up in Round 2 of the EY Case Study Competition.
At PharmacyFreak.com, I aim to guide future pharmacists through expert content, exam strategies, and insightful resources based on real experience and academic excellence.
Mail- harsh@pharmacyfreak.com